- Young, Lucy C;
- Goldstein de Salazar, Ruby;
- Han, Sae-Won;
- Huang, Zi Yi Stephanie;
- Merk, Alan;
- Drew, Matthew;
- Darling, Joseph;
- Wall, Vanessa;
- Grisshammer, Reinhard;
- Cheng, Alice;
- Allison, Madeline R;
- Sale, Matthew J;
- Nissley, Dwight V;
- Esposito, Dominic;
- Ognjenovic, Jana;
- McCormick, Frank
The majority of pathogenic mutations in the neurofibromatosis type I (NF1) gene reduce total neurofibromin protein expression through premature truncation or microdeletion, but it is less well understood how loss-of-function missense variants drive NF1 disease. We have found that patient variants in codons 844 to 848, which correlate with a severe phenotype, cause protein instability and exert an additional dominant-negative action whereby wild-type neurofibromin also becomes destabilized through protein dimerization. We have used our neurofibromin cryogenic electron microscopy structure to predict and validate other patient variants that act through a similar mechanism. This provides a foundation for understanding genotype-phenotype correlations and has important implications for patient counseling, disease management, and therapeutics.